Santel SRL
Santel reported total assets of 146,637 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of Santel shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +204 % Total assets +206 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Santel's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 34,510 € | ||||
| Equity | 106,384 € | ||||
| Cash | 88,255 € | ||||
| EBITDA | 53,235 € | ||||
| Total assets | 146,637 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 07 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 04 Aug 2022
Santel's financial analysis
- Solvency72.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Santel
Santel's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.631.519
- VAT number
- BE0762631519
- Peppol
- Registered · 0208:0762631519 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Jan 2021
- Registered office
- 6280 Gerpinnes
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Santel (SRL) has been based in Gerpinnes since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 34,510 € and equity of 106,384 €; its revenue is not published. Its solvency stands at 72.5%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Santel
Companies in the same business, of comparable size and area, outside its group.
- Apo Kuipers Retail sale of pharmaceutical products Lubbeek · balance sheet 146,357 €
- Pribe Retail sale of pharmaceutical products Roeselare · balance sheet 123,987 €
- Apotheker Delcourt Retail sale of pharmaceutical products Lennik · balance sheet 171,416 €
- Vroome Pharma Management Retail sale of pharmaceutical products Antwerp · balance sheet 229,894 €
- ENNC Retail sale of pharmaceutical products Oud-Heverlee · balance sheet 149,458 €
- Ve² Consult Retail sale of pharmaceutical products Mechelen · balance sheet 140,720 €
- Management Consulting Pharma Retail sale of pharmaceutical products Perwez · balance sheet 155,710 €
- Chi-LiVita Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet 340,234 €
Frequently asked questions about Santel
What is the revenue of Santel?
Santel files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Santel?
In Belgium, the VAT number is the company number prefixed with BE: BE0762631519 for Santel, if the company is VAT-registered. Its company number (CBE) is 0762.631.519.
Where is the registered office of Santel?
According to the CBE register, the registered office of Santel is in 6280 Gerpinnes.
What is the equity of Santel?
At the close of the 2025 financial year, the equity of Santel amounts to 106,384 €, a solvency of 72.5% of total assets.
Who manages Santel?
The register lists 1 active mandates at Santel. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Santel
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →